Professors Rochelle Dreyfuss and Katherine Strandburg

Spring 2012

Topic: To examine innovation in the health care field, looking at such matters as the relationship between intellectual property, encouraging medical advances, and assuring appropriate public access to these advances; the special problem of developing countries; rights over personal patient data and the use of such data in research and marketing; the impact of personalized medicine on IP paradigms; controversial attempts to deal with the trade in counterfeit drugs; and competition issues related to innovation and intellectual property.

Thursday, January 26

Heidi Williams, Assistant Professor, MIT Department of Economics
Intellectual Property Rights and Innovation: Evidence from the Human Genome

Thursday, February 9

Christopher Beauchamp, Assistant Professor of Law, Brooklyn Law School
The Pure Thoughts of Judge Hand: A Historical Note on the Patenting of Nature

Thursday, February 16

Walter Powell, Professor of Education; Professor of Sociology, Organizational Behavior, Management Science, Communication, and Public Policy, Stanford University, Department of Education
Amphibious Entrepreneurs and the Emergence of Organizational Forms

Thursday, February 23

Barbara Evans, Professor of Law, University of Houston Law Center
Data Access for 21st-Century Biomedical Innovation

Thursday, March 1

Kara Swanson, Associate Professor of Law, Northeastern University School of Law
Patents, Politics, and Abortion

Thursday, March 22

Guy David, Assistant Professor of Health Care Management, The Wharton School, University of Pennsylvania
Pharmaceuticals and Advertising: The Effects of Pharmaceutical Marketing and Side Effects of Competition

Thursday, March 29

Angelina Godoy, Associate Professor of Law, Societies, and Justice, and of International Studies, University of Washington, Sociology Department
Writing Globalization's Rulebook: Health, Human Rights, and Intellectual Property in Central America

Thursday, April 5

Ian Kerr, Canada Research Chair in Ethics, Law & Technology, Faculty of Law, University of Ottawa [CANCELLED]
The Repo Men Reductio Body: EULAs, Privacy and Security of the Person

ABSTRACT: Recent medical advances allow us to transcend biological limitations through the implantation of microchips, digital body parts and artificial organs. However, surprisingly little thought has been given to the ethical and legal aspects of their design and use. In this seminar, Ian Kerr, Canada Research Chair in Ethics, Law and Technology, examines current ethical and regulatory approaches that govern medical devices and argues that the existing paradigm of mass-market consumer goods is not particularly well suited for the health sector. His primary concern is that individuals are increasingly called upon to sign complex contractual documents that diminish privacy and autonomy not only as users of mass market consumer goods but, now, as medical patients. Drawing on lessons learned in the field of privacy and information technology law, he suggests that special considerations are required in the healthcare context to ensure that patient autonomy and privacy are adequately protected in an era where our bodies are becoming inextricably tethered by devices and software owned by health care providers in partnership with industry.

The Colloquium meets at NYU School of Law, Vanderbilt Hall, 40 Washington Square South, room 208 from 4:00-6:00pm.

2 New York CLE Credits are available in the area of Professional Practice for each colloquia you attend.